Adiuvo Investments SA logo

ADV - Adiuvo Investments SA Share Price

PLN4.3 -0.1  -2.3%

Last Trade - 12/08/20

Sector
Financials
Size
Micro Cap
Market Cap £11.6m
Enterprise Value £16.6m
Revenue £321k
Position in Universe 461st / 748
Bullish
Bearish
Unlock ADV Revenue
Momentum
Relative Strength (%)
1m -9.92%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -51.1%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.036 3.94 4.78 5.76 2.79 1.78 +118.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Adiuvo Investments SA revenues decreased 54% to PLN185K. Net loss applicable to common stockholders totaled PLN3.2M vs. income of PLN266K. Revenues reflect Nutraceutical Platform segment decrease of 55% to PLN148K, Medical Equipment segment decrease of 49% to PLN37K. Net loss reflects Nutraceutical Platform segment loss totaling PLN1M vs. income of PLN1.3M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

ADV Revenue Unlock ADV Revenue

Net Income

ADV Net Income Unlock ADV Revenue

Normalised EPS

ADV Normalised EPS Unlock ADV Revenue

PE Ratio Range

ADV PE Ratio Range Unlock ADV Revenue

Dividend Yield Range

ADV Dividend Yield Range Unlock ADV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ADV EPS Forecasts Unlock ADV Revenue
Profile Summary

Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated August 24, 2012
Public Since May 27, 2015
No. of Shareholders: n/a
No. of Employees: 18
Sector Financials
Industry Investment Banking & Investment Services
Index
Exchange Warsaw Stock Exchange
Shares in Issue 13,174,346
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ADV Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ADV
Upcoming Events for ADV
Frequently Asked Questions for Adiuvo Investments SA
What is the Adiuvo Investments SA share price?

As of 12/08/20, shares in Adiuvo Investments SA are trading at PLN4.3, giving the company a market capitalisation of £11.6m. This share price information is delayed by 15 minutes.

How has the Adiuvo Investments SA share price performed this year?

Shares in Adiuvo Investments SA are currently trading at PLN4.3 and the price has moved by -44.16% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Adiuvo Investments SA price has moved by -43.94% over the past year.

What are the analyst and broker recommendations for Adiuvo Investments SA?

Of the analysts with advisory recommendations for Adiuvo Investments SA, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Adiuvo Investments SA is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Adiuvo Investments SA next release its financial results?

Adiuvo Investments SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Adiuvo Investments SA dividend yield?

Adiuvo Investments SA does not currently pay a dividend.

Does Adiuvo Investments SA pay a dividend?

Adiuvo Investments SA does not currently pay a dividend.

When does Adiuvo Investments SA next pay dividends?

Adiuvo Investments SA does not currently pay a dividend.

How do I buy Adiuvo Investments SA shares?

To buy shares in Adiuvo Investments SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Adiuvo Investments SA?

Shares in Adiuvo Investments SA are currently trading at PLN4.3, giving the company a market capitalisation of £11.6m.

Where are Adiuvo Investments SA shares listed? Where are Adiuvo Investments SA shares listed?

Here are the trading details for Adiuvo Investments SA:

Country of listing: Poland
Exchange: WSE
Ticker Symbol: ADV
What kind of share is Adiuvo Investments SA?

Based on an overall assessment of its quality, value and momentum, Adiuvo Investments SA is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Adiuvo Investments SA share price forecast 2020?

We were not able to load any forecast data for Adiuvo Investments SA.

How can I tell whether the Adiuvo Investments SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adiuvo Investments SA. Over the past six months, the relative strength of its shares against the market has been -18.99%. At the current price of PLN4.3, shares in Adiuvo Investments SA are trading at -22.49% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Adiuvo Investments SA PE Ratio?

We were not able to find PE ratio data for Adiuvo Investments SA.

Who are the key directors of Adiuvo Investments SA?

Adiuvo Investments SA's management team is headed by:

Marek Orlowski - CMG
Anna Aranowska-Bablok - MGB
Pawel Nauman - SUB
Wojciech Napiorkowski - SUB
Krzysztof Laskowski - IND
Dariusz Zimny - IND
Filip Elzanowski - SUB
Wojciech Bablok - SUB
Who are the major shareholders of Adiuvo Investments SA?

Here are the top five shareholders of Adiuvo Investments SA based on the size of their shareholding:

Porozumienie akcjonariuszy: Orenore sp. z o.o. i Morluk sp. Corporation
Percentage owned: 57.39% (7.56m shares)
Aviva OFE BZ WBK Pension Fund Portfolio
Percentage owned: 9.36% (1.23m shares)
Aviva Powszechne Towarzystwo Emerytalne Aviva Santander SA Pension Fund
Percentage owned: 9.36% (1.23m shares)
Bablok (Anna Aranowska) Individual Investor
Percentage owned: 6.76% (890k shares)
Investors Towarzystwo Funduszy Inwestycyjnych S.A. Investment Advisor
Percentage owned: 5.48% (723k shares)
Similar to ADV
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.